PATENT: Dr. Magliato holds the following patent:
“METHOD AND DEVICE FOR DETECTING AND ASSESSING REACTIVE HYPEREMIA USING SEGMENTAL PLETHYSMOGRAPHY”
International Application number: PCT/US2010/001605
Filed June 2, 2010
United States Application Number: 61/208,547
Filed February 26, 2009
Dr. Magliato is involved with the following medical technology companies either as an officer, advisor, or board member:
CARDIOMAG IMAGING INC. – this company has an FDA cleared imaging device that can image the heart for ischemia (loss of blood flow that results in a heart attack) without the use of harmful radiation. This diagnostictest is passive, non-invasive and takes approximately 9 minutes to complete. www.cardiomag.com
JARVIK HEART INC. – this company has developed an artificial heart technology that uses an axial flow pump to support the heart in patients with severe heart failure as a bridge to transplant. For the past 6 years, Dr. Magliato has served as the Chairman of the Clinical Events Committee for the US human clinical trial that is currently underway. www.jarvikheart.com
DATA PHYSICS RESEARCH INC. – this company has developed “intuitive visualization” for use by radiologists. This software platform organizes, manages, analyzes and reports radiologic information that accelerates the reading and reporting of diagnostic images and improves diagnostic accuracy. www.dpresearch.com
TAGNOS INC. – this company has developed a real-time patient tracking system to be used within a hospital setting. It allows a hospital to monitor patient flow and throughput to increase patient safety as well as create better transport efficiency and patient throughput. The system is currently in use in 5 hospitals in California. www.tagnos.com
NANOMERSION INC. – this early stage company is developing a nanoparticle that can cross the blood brain barrier and potentially deliver chemotherapeutic drugs to brain tumors. It may also be used for special brain imaging.
LKC TECHNOLOGIES INC. – this company is a world leader in visual electrophysiology which is currently working on a new device for the early detection of diabetic retinopathy- a leading cause of blindness. www.lkc.com
